Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/04/2022* -- Results Q3 2022 -- 0.31 --
11/04/2022* 17:00 EST Earnings Call Q3 2022 -- -- --
08/11/2022 -- Results Q2 2022 0.57 0.64 -11.56%
08/11/2022 17:00 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q1 2022 1.07 0.89 20.78%
05/05/2022 17:00 EST Earnings Call Q1 2022 -- -- --
02/10/2022 -- Results Q4 2021 0.75 0.49 54.51%
02/10/2022 17:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/04/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/11/2022
Beat/Miss Upgrade
Return Since -19.05%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
URL https://www.illumina.com
Investor Relations URL https://investor.illumina.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 11, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
3.99%
-33.29%
70.64%
37.27%
10.61%
11.53%
2.82%
-51.60%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-22.42%
--
--
--
--
107.9%
64.93%
-22.39%
-51.96%
19.39%
-0.14%
43.75%
-2.35%
23.85%
5.89%
50.59%
-26.56%
-66.36%
44.75%
293.3%
20.10%
46.56%
43.26%
-41.26%
-58.45%
--
8.43%
-23.23%
55.28%
141.3%
195.4%
-6.16%
-54.44%
As of September 26, 2022.

Profile

Edit
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
URL https://www.illumina.com
Investor Relations URL https://investor.illumina.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 11, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
HQL 24.54M USD 5.02%
BBH 18.25M USD 4.42%
EGFFX 841.18M USD 4.38%
HQH 44.28M USD 4.35%
BMO78213 53.02M USD 4.21%
FBT 43.15M USD 3.53%
IBB 230.69M USD 3.12%
ZCG.TO 57.54M USD 2.88%
LGRCX 221.98M USD 1.96%
VWIGX 717.17M USD 1.68%
POLRX 128.79M USD 1.34%
VWUSX 232.71M USD 0.72%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ILMN Tweets